File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: A Phase 2 Study of the LSD1 Inhibitor Bomedemstat (IMG-7289) for the Treatment of Essential Thrombocythemia (ET)

TitleA Phase 2 Study of the LSD1 Inhibitor Bomedemstat (IMG-7289) for the Treatment of Essential Thrombocythemia (ET)
Authors
Gill, HPalandri, FRoss, DMCochrane, TTate, CLane, SWLarsen, SRGerds, ATHalpern, ABShortt, JRossetti, JMPettit, KMLiang, JMead, AJMarchetti, MVannucchi, AMWilson, AJGothert, JRHanna, MERITPassamonti, FStevenson, WSHarrison, CTalpaz, MVianelli, NRienhoff, HY
Issue Date2022
PublisherAmerican Society of Hematology. The Journal's web site is located at http://bloodjournal.hematologylibrary.org/
Citation
64th ASH Annual Meeting and Exposition (Virtual), New Orleans, Louisiana, United States, December 10-13, 2022. In Blood, v. 140 n. S1, p. 1784-1787 How to Cite?
DOI: http://dx.doi.org/10.1182/blood-2022-159047
Description634.Myeloproliferative Syndromes: Clinical and Epidemiological
Persistent Identifierhttp://hdl.handle.net/10722/323334
ISI Accession Number ID
WOS:000893223201326

 

DC FieldValueLanguage
dc.contributor.authorGill, H-
dc.contributor.authorPalandri, F-
dc.contributor.authorRoss, DM-
dc.contributor.authorCochrane, T-
dc.contributor.authorTate, C-
dc.contributor.authorLane, SW-
dc.contributor.authorLarsen, SR-
dc.contributor.authorGerds, AT-
dc.contributor.authorHalpern, AB-
dc.contributor.authorShortt, J-
dc.contributor.authorRossetti, JM-
dc.contributor.authorPettit, KM-
dc.contributor.authorLiang, J-
dc.contributor.authorMead, AJ-
dc.contributor.authorMarchetti, M-
dc.contributor.authorVannucchi, AM-
dc.contributor.authorWilson, AJ-
dc.contributor.authorGothert, JR-
dc.contributor.authorHanna, MERIT-
dc.contributor.authorPassamonti, F-
dc.contributor.authorStevenson, WS-
dc.contributor.authorHarrison, C-
dc.contributor.authorTalpaz, M-
dc.contributor.authorVianelli, N-
dc.contributor.authorRienhoff, HY-
dc.date.accessioned2022-12-09T10:44:55Z-
dc.date.available2022-12-09T10:44:55Z-
dc.date.issued2022-
dc.identifier.citation64th ASH Annual Meeting and Exposition (Virtual), New Orleans, Louisiana, United States, December 10-13, 2022. In Blood, v. 140 n. S1, p. 1784-1787-
dc.identifier.urihttp://hdl.handle.net/10722/323334-
dc.description634.Myeloproliferative Syndromes: Clinical and Epidemiological-
dc.languageeng-
dc.publisherAmerican Society of Hematology. The Journal's web site is located at http://bloodjournal.hematologylibrary.org/-
dc.relation.ispartofBlood-
dc.titleA Phase 2 Study of the LSD1 Inhibitor Bomedemstat (IMG-7289) for the Treatment of Essential Thrombocythemia (ET)-
dc.typeConference_Paper-
dc.identifier.emailGill, H: gillhsh@hku.hk-
dc.identifier.authorityGill, H=rp01914-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1182/blood-2022-159047-
dc.identifier.hkuros342983-
dc.identifier.volume140-
dc.identifier.issueS1-
dc.identifier.spage1784-
dc.identifier.epage1787-
dc.identifier.isiWOS:000893223201326-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats